Moore v. Regents of the University of California

In 1976, John Moore was treated for hairy cell leukemia by physician David Golde, a cancer researcher at the UCLA Medical Center.

The California Supreme Court ruled that a hospital patient's discarded blood and tissue samples are not his personal property and that individuals do not have rights to a share in the profits earned from commercial products or research derived from their cells.

It said the hospital could "dispose of any severed tissue or member by cremation", and his spleen was removed by surgeons, who were not named as defendants, at UCLA Medical Center.

[5] Moore moved to Seattle, Washington, after his surgery and returned to the UCLA Medical Center for follow-up visits with Golde several times, between 1976 and 1983.

[4] After a few years of traveling back to Los Angeles to see Golde and to have samples taken of bone marrow, blood, and semen, Moore asked about transferring his care to a doctor closer to home.

[3] In 1983, Moore became suspicious about a new consent form he was asked to sign that said, "I (do, do not) voluntarily grant to the University of California all rights I, or my heirs, may have in any cell line or any other potential product which might be developed from the blood and/or bone marrow obtained from me".

Genetics Institute also agreed to pay Golde and the regents at least $330,000 over three years, in exchange for exclusive access to the materials and research performed on the cell line and products derived from it.

[citation needed] After learning of the patent, Moore filed a lawsuit for a share in the potential profits from products or research that had been derived from his cell line, without his knowledge or consent.

Justice Arabian wrote a concurring opinion, stating that the deep philosophical, moral and religious issues presented by the case could not be decided by the court.

Thus, there would be no necessity to hold labs strictly liable for conversion when property rights could be broken up, to allow Moore to extract a significant portion of the economic value created by his tissue.